Commercial-stage medical technology company
Irras has raised €10M across 1 funding round from 2 investors, most recently a Growth/Late round in May 2016. Based in Stockholm, Sweden; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-05-01 | Growth/Late |
| €10M |
| Ixora Ventures,Vandel Group |
| View deal → |
